AzTrials
AzTrials

MalnutritionNCT03391752

More-2-Eat Phase 2: Scaling and Spread of the Integrated Nutrition Pathway for Acute Care

An observational study of Malnutrition, run by University of Waterloo at 9 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

More-2-Eat Phase 2 provides the opportunity to extend the implementation of the Integrated Nutrition Pathway to a total of 10 hospitals and more than 20 medical/surgical units. Building on the success of More-2-Eat Phase 1, key components of this implementation study will be a registry for self-managed data entry and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Malnutrition
What is being tested?
Integrated Nutrition Pathway for Acute Care
Type of treatment
Pill or oral medicine
How many people
5,158 participants
Where
9 sitesCanada
Study dates
1 May 2018to 31 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: all patients admitted to study units in one of the 10 hospitals included will be subject to the improved nutrition care processes; those that are malnourished will be offered a variety of treatments including medication pass

Who may be able to join

  • Patient on the study unit

Who cannot join

  • patients not on the study unit

Trial locations and contacts

9 sites in 1 country.

9 sites in 1 country

Canada9 sites
  • Brandon Regional Health Centre

    Brandon, Manitoba

  • Royal Alexander Hospital

    Edmonton, Alberta

  • Victoria General Hospital

    Halifax, Nova Scotia

  • London Health Sciences Centre

    London, Ontario

  • Lennox Addington County General Hospital

    Napanee, Ontario

  • Niagara Health Systems

    Niagara Falls, Ontario

  • Pasqua Hospital

    Regina, Saskatchewan

  • Thunder Bay Regional Health Sciences Centre

    Thunder Bay, Ontario

  • Concordia Hospital

    Winnipeg, Manitoba

Other trials in Canada

About this study

Official title: More-2-Eat Phase 2: Spread/Scaling up Improved Nutrition Care to Detect and Treat Hospital Malnutrition.

More-2-Eat Phase 2 provides the opportunity to extend the implementation of the Integrated Nutrition Pathway to a total of 10 hospitals and more than 20 medical/surgical units. Building on the success of More-2-Eat Phase 1, key components of this implementation study will be a registry for self-managed data entry and reports and a community of practice to support implementation of nutrition screening at admission to hospital, subjective global assessment to diagnose and triage patients to care pathways and medication pass of a small amount of nutrient dense oral nutritional supplement. Success with implementation and impact on key patient outcomes will be determined.

Read the detailed description

Malnutrition in hospital patients is a growing problem, with 20-45% of patients already malnourished at admission. As 70% of malnourished patients are also frail, early detection and treatment of malnutrition is one way to improve the outcomes of frail older adults. To improve the detection and treatment of these conditions, the PI developed the Integrated Nutrition Pathway for Acute Care (INPAC) that guides hospital staff on when to conduct key nutrition care activities to improve outcomes (e.g. screening at admission).

In More-2-Eat (April 2015-March 2017), 5 Canadian hospital units in 4 provinces received funding to implement INPAC. Each hospital, with support from a research team had 1 year to implement INPAC. All 5 hospitals were successful in improving detection and treatment of malnutrition, and started to screen for frailty. Clinical care was transformed in the study units; for example all sites progressed from low baseline or no screening at admission to a rate of 75%. Findings also demonstrate improvement in clinical outcomes such as a shorter length of stay. An online INPAC Implementation Toolkit was developed to promote mobilization of this knowledge. What is not known is whether or not the results can be replicated under normal circumstances (i.e., no external funding for implementation at a hospital site).

To sustain and expand on this success, a Phase 2 knowledge translation project is proposed that will involve the five original Phase 1 sites and five further hospitals as Phase 2 sites. The goal of the second phase is to see if Phase 1 sites can spread success to other units within their hospitals and if Phase 2 sites can achieve similar results across a broader group of patients.

The end product will be a sustainable model including a community of practice supported by our partner the Canadian Malnutrition Task Force, and a self-serve registry that allows sites to collect and report data to change their practice. Investigators will also confirm capacity of INPAC activities to improve clinical outcomes across diverse settings. This knowledge translation and implementation study will demonstrate the potential to transform clinical nutrition care, benefiting all pre-frail and frail older adults.

Conditions
Malnutrition
Being tested
Integrated Nutrition Pathway for Acute Care
Keywords
malnutrition, screening, assessment, treatment
Medical subject headings
Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Integrated Nutrition Pathway for Acute CareCombination product

    algorithm to guide care processes with respect to nutrition e.g. screening on admission, diagnosis with subjective global assessment, early treatment with medication pass of oral nutritional supplement

Study groups in NCT03391752
Study groupRoleWhat they receive
Royal AlexandriaAdministrative records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Pasqua Regional hospitalAdministrative records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Concordia HospitalAdministrative records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Niagara General HospitalAdministrative records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Hospital 6Administrative Records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Hospital 7Administrative Records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Hospital 8Administrative Records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Hospital 9Administrative Records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care
Hospital 10Administrative records
Receives: Combination Product: Integrated Nutrition Pathway for Acute Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. success with implementation

    rates of screening, diagnosis and treatment with medication pass per month of the study

    Measured: 19 months

Secondary outcomes (3)
  1. Adverse events while in hospital (fall, new infection etc.)

    Measured: 19 months

  2. Length of stay

    Average length of stay for patients admitted to the study unit; monthly average

    Measured: 19 months

  3. Readmission rate

    number of patients per month discharged and readmitted to the hospital within 30 days

    Measured: 19 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2018
  2. Study start1 May 2018
  3. Primary completion30 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
5,158 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03391752
Sponsor's protocol ID
KT2017-01
Status last verified
Feb 2020
First submitted
1 Jan 2018
Last updated
11 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: UWSpace at the University of Waterloo

Publications

  • Laur C, Bell J, Valaitis R, Ray S, Keller H. The role of trained champions in sustaining and spreading nutrition care improvements in hospital: qualitative interviews following an implementation study. BMJ Nutr Prev Health. 2021 Sep 28;4(2):435-446. doi: 10.1136/bmjnph-2021-000281. eCollection 2021.

    PubMed 35028514

Questions about this trial

What is this clinical trial studying?

An observational study of Malnutrition, run by University of Waterloo at 9 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

success with implementation (time frame: 19 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03391752, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in